Compare StocksABBV vs CSGP

AbbVie Inc. (ABBV) vs CoStar Group, Inc. (CSGP): Which Is the Better Buy in 2026?

As of 2026-06-19, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. CSGP is overvalued at $30, with an intrinsic value of $1 and a margin of safety of -1979%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
CSGP
CoStar Group, Inc.
$30.12

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
CSGP
  • Gross margin of 78.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Trailing P/E of 430.3x is 54% below the historical average of 937.7x — potentially undervalued relative to its own history.
  • PEG ratio of 0.12 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 105.6x is 69% above the historical average of 62.3x — the stock trades at a premium to its own history.
CSGP
  • FCF yield of 1.6% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • Free cash flow has declined at a 52.6% CAGR over the past 4 years — a concerning trend.

Key Valuation Metrics

Learn more →
ABBV
CSGP
Valuation
$20.81B
Free Cash Flow
$202.20M
5.44%
FCF Yield
1.64%
105.60
Trailing P/E
430.29
13.32
Forward P/E
16.75
Quality & Moat
21.89%
ROIC
0.10%
N/A
ROE
0.30%
72.03%
Gross Margin
78.63%
0.61
PEG Ratio
0.12
Balance Sheet Safety
N/A
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
-0.22
3.11%
Dividend Yield
0.00%
ABBV: 6Ties: 1CSGP: 3
ABBVCSGP

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

CSGP

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CSGP
$-6.39
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$521.0M
Δ Market Cap
$-3.33B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CSGP
1978.8% Overvalued
Price is 1978.8% above estimated fair value
Current Price: $30.12
Fair Value: $1.45
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

CSGP

What growth rate is the market pricing in at $30?

+60.0%
Market-Implied Owner Earnings Growth
Standard FCF implies +22.8%

The market implies +60.0% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +22.8%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CSGP
37/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though revenue predictability shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CSGP
-2.07
Possible Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,106
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CSGP
Insiders 1.2%Institutions 104.0%
No. of Institutional Holders1,167
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
CSGP
1
Buys (3M)
5
Buys (12M)
Total value (12M): $5.99M
FLORANCE ANDREW COLDEN
Chief Executive Officer
$2.51M
@ $35.20 · 2026-05-01
SAMS LOUISE S.
Director
$48,360
@ $48.36 · 2026-03-06
GLASER RACHEL C
Director
$44,940
@ $44.94 · 2026-03-02
SAINT FREDERICK G
Officer
$906,600
@ $45.33 · 2026-03-02
FLORANCE ANDREW COLDEN
Chief Executive Officer
$2.48M
@ $44.52 · 2026-02-27
FLORANCE ANDREW COLDEN
Chief Executive Officer
$1.10M
@ $74.67 · 2024-10-25
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CSGP
0
Sells (3M)
5
Sells (12M)
Total value (12M): $5.06M
CANN CYNTHIA CAMMETT
Officer
$126,642
@ $68.79 · 2025-11-13
HILL JOHN W
Director
$154,530
@ $68.68 · 2025-11-13
SAINT FREDERICK G
Officer
$2.26M
@ $90.33 · 2025-08-28
CANN CYNTHIA CAMMETT
Officer
$188,764
@ $92.85 · 2025-07-28
SAINT FREDERICK G
Officer
$2.33M
@ $93.23 · 2025-07-28
SAINT FREDERICK G
Officer
$2.03M
@ $81.10 · 2025-06-11
CANN CYNTHIA CAMMETT
Officer
$334,259
@ $78.48 · 2025-03-10
HILL JOHN W
Director
$209,939
@ $76.76 · 2024-12-10
NASSETTA CHRISTOPHER J
Director
$135,136
@ $80.39 · 2024-11-27
DESMARAIS MICHAEL J
Officer
$439,340
@ $79.88 · 2024-11-26
KLEIN MICHAEL R
Director
$5.35M
@ $74.69 · 2024-10-25
HILL JOHN W
Director
$103,562
@ $78.16 · 2024-07-30
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CSGP
FearGreed
😨Fear(30/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
CSGP
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (30)
View ABBV Full AnalysisView CSGP Full Analysis

Frequently Asked Questions: ABBV vs CSGP

Is AbbVie Inc. or CoStar Group, Inc. more undervalued in 2026?

Based on our discounted cash flow model, ABBV trades at a -35.3% margin of safety (intrinsic value $160 vs. price $216), compared to CSGP's -1978.8% margin of safety (intrinsic $1 vs. $30).

Which stock has a wider economic moat, AbbVie Inc. or CoStar Group, Inc.?

ABBV scores 82/100 (Wide moat), while CSGP scores 37/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. CSGP scores 8.5 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, AbbVie Inc. or CoStar Group, Inc.?

AbbVie Inc. (ABBV) generates a 5.4% free cash flow yield, compared to CoStar Group, Inc.'s 1.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or CoStar Group, Inc.?

ABBV earns 21.9% ROIC versus CSGP's 0.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.